Study for mechanism of protein disulfide isomerase-mediated GP IIb/IIIa receptor involved in platelet activation of diabetes

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000032746

Enrollment

Unknown

Registered

2020-05-09

Start date

2018-01-01

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetds, coronary heart disease

Interventions

Two groups:none

Eligibility

Sex/Gender

All

Age

30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for CHD: one or more coronary arteries had stenosis >=50% based on coronary angiography or coronary CTA results. Type 2 diabetes was diagnosed according to the Guidelines for the prevention and treatment of type 2 diabetes in China 2017.

Exclusion criteria

Exclusion criteria: Patients with valvular heart disease, history of malignant tumors, hematopoietic system disease, rheumatic immune system disease, severe infectious diseases, undergoing hormone replacement therapy, underwent coronary stent implantation, atrial fibrillation, acute myocardial infarction and grade III-IV cardiac function.

Design outcomes

Primary

Measure	Time frame
platelet activation;	—

Countries

China

Contacts

Public ContactZhi-hao Wang

Department of Geriatric Medicine, Qilu Hospital

wangzhihaosdu@126.com+86 0531 86169356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026